Health
UCLH doses first patient in the world in Covid-19 antibody trial – University College London Hospitals
UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.
UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.
Researchers in the STORM CHASER study led by UCLH virologist Dr Catherine Houlihan recruited the first participant in the world to the study earlier this month and have recruited 10 participants to date.
They believe the antibody or LAAB, known as AZD7442 and developed by AstraZeneca, may offer immediate and long-term protection to people who have…
-
General14 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
General22 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General21 hours agoWarner Bros Discovery board rejects rival $163bn bid from Paramount
-
Noosa News13 hours agoE-Scooter accident | Noosa Today